HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CIR Panel To Reopen Parabens Review To Consider New Data

This article was originally published in The Rose Sheet

Executive Summary

The Cosmetic Ingredient Review Expert Panel will re-review the safety of parabens following the emergence of new data, the panel decided at a meeting in Washington, D.C. June 28-29. Parabens were evaluated by CIR and found to be safe as used in 1984

You may also be interested in...



Parabens “Safe As Used” In Cosmetics, CIR Concludes

The Cosmetic Ingredient Review Expert Panel issued a final amended report for parabens after reviewing a male reproductive study on the ingredient and research on breast cancer cells (see chart: "1Cosmetic Ingredient Review Report Status"). The panel reached its decision during its June 12-13 meeting in Washington, D.C

Parabens “Safe As Used” In Cosmetics, CIR Concludes

The Cosmetic Ingredient Review Expert Panel issued a final amended report for parabens after reviewing a male reproductive study on the ingredient and research on breast cancer cells (see chart: "1Cosmetic Ingredient Review Report Status"). The panel reached its decision during its June 12-13 meeting in Washington, D.C

Parabens Tentative Amended Final Report Issued By CIR

The Cosmetic Ingredient Review Expert Panel is initiating a 90-day comment period on a tentative amended final safety assessment for parabens, which the panel issued during its Dec. 12-13 meeting in Washington, D.C

Related Content

Latest News
See All
UsernamePublicRestriction

Register

RS012258

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel